From therapeutic benefit to cardiovascular risk: a multidisciplinary review on anabolic steroids
International Health Sciences Review · 11.08.2026 · 2 (4)
DOI: 10.70164/ihsr.v2i4.209 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 11.08.2026. Verfasst von Ana Clara Pessoa Pontes und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anabolic-androgenic steroids (AAS) have established therapeutic applications, particularly testosterone replacement therapy in men with hypogonadism; however, non-therapeutic use at supraphysiological doses is associated with important cardiovascular consequences. This narrative review synthesizes recent evidence on the mechanisms, risks, and clinical implications of AAS use, emphasizing the distinction between supervised therapeutic treatment and abuse. Evidence from randomized clinical trials, including the TRAVERSE and T4DM studies, indicates that testosterone replacement therapy, when appropriately indicated and monitored, does not increase the risk of major cardiovascular events, although it may be associated with arrhythmias and thromboembolic events. In contrast, observational studies demonstrate that abusive AAS use is associated with higher incidences of acute myocardial infarction, cardiomyopathy, arrhythmias, venous thromboembolism, hypertension, and dyslipidemia. The underlying mechanisms include androgen receptor overactivation, oxidative stress, endothelial dysfunction, pathological cardiac remodeling, myocardial fibrosis, lipid abnormalities, and prothrombotic effects. The magnitude of cardiovascular damage appears to depend primarily on dose, duration, and cumulative exposure, as well as the simultaneous use of multiple compounds. Clinical management should therefore adopt a multidisciplinary approach involving cardiology, endocrinology, psychiatry, and sports medicine, with individualized strategies for cardiovascular screening, risk prevention, patient education, and harm reduction.
Zitieren
APA
Pontes, A. C. P., Dutra, J. S., Carvalho, F. A. D., Camargo, C. L. D., Carvalho, A. L. G. D., Alves, A. M., Marques, T. C., Lima, H. B. F. D., Oliveira, L. B. D., Veiga, L. D. L., Bonatto, S., Paiva, R. G. D., Rocha, M. P., & Camargo, M. J. D. (2026). From therapeutic benefit to cardiovascular risk: a multidisciplinary review on anabolic steroids. International Health Sciences Review, 2(4). https://doi.org/10.70164/ihsr.v2i4.209
Vancouver
Pontes ACP, Dutra JS, Carvalho FAD, Camargo CLD, Carvalho ALGD, Alves AM, et al. From therapeutic benefit to cardiovascular risk: a multidisciplinary review on anabolic steroids. International Health Sciences Review. 2026;2(4). doi:10.70164/ihsr.v2i4.209
BibTeX
@article{Pontes2026,
author = {Pontes, Ana Clara Pessoa and Dutra, Janaína Soares and Carvalho, Fábio Andrade De and Camargo, Carla Lúcia De and Carvalho, Ana Luisa Gordiano De and Alves, Andres Mesquita and Marques, Tamara Cotrim and Lima, Helvis Bonfim Felipe De and Oliveira, Letícia Braga De and Veiga, Larissa de Leite and Bonatto, Steffany and Paiva, Rodrigo Gamalier De and Rocha, Márcio Pimentel and Camargo, Milene Jakobi De},
title = {From therapeutic benefit to cardiovascular risk: a multidisciplinary review on anabolic steroids},
journal = {International Health Sciences Review},
year = {2026},
volume = {2},
number = {4},
doi = {10.70164/ihsr.v2i4.209}
}
EUVIMED